These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Rationale for use of lower estrogen doses for postmenopausal hormone therapy. Ettinger B Maturitas; 2007 May; 57(1):81-4. PubMed ID: 17383126 [TBL] [Abstract][Full Text] [Related]
25. Estriol: safety and efficacy. Head KA Altern Med Rev; 1998 Apr; 3(2):101-13. PubMed ID: 9577246 [TBL] [Abstract][Full Text] [Related]
26. Estrogen use and postmenopausal women: a basis for informed decisions. NIH Consensus Development. Gastel B; Cornoni-Huntley J; Brody JA J Fam Pract; 1980 Nov; 11(6):851-60. PubMed ID: 7005387 [TBL] [Abstract][Full Text] [Related]
27. Are older breast carcinoma survivors willing to take hormone replacement therapy? Ganz PA; Greendale GA; Kahn B; O'Leary JF; Desmond KA Cancer; 1999 Sep; 86(5):814-20. PubMed ID: 10463980 [TBL] [Abstract][Full Text] [Related]
28. [General undifferentiated estrogen (progestagen) substitution in the prevention of osteoporosis: contra]. Ziegler R Med Klin (Munich); 1987 Mar; 82(6):241-4. PubMed ID: 3587169 [No Abstract] [Full Text] [Related]
29. [Oral hormone therapy in the pre- and postmenopausal period]. Braendle W; Bettendorf G Gynakologe; 1986 Dec; 19(4):235-40. PubMed ID: 3817595 [No Abstract] [Full Text] [Related]
30. Hormone replacement therapy in postmenopausal women. Yasui T; Uemura H; Takikawa M; Irahara M J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382 [TBL] [Abstract][Full Text] [Related]
31. Current trends in hormone replacement therapy. Khashoggi TY Saudi Med J; 2002 May; 23(5):495-502. PubMed ID: 12070567 [TBL] [Abstract][Full Text] [Related]
33. Isoflavone treatment for acute menopausal symptoms. Cheng G; Wilczek B; Warner M; Gustafsson JA; Landgren BM Menopause; 2007; 14(3 Pt 1):468-73. PubMed ID: 17290160 [TBL] [Abstract][Full Text] [Related]
34. The menopause in Europe. Rozenberg S; Fellemans C; Kroll M; Vandromme J Int J Fertil Womens Med; 2000; 45(2):182-9. PubMed ID: 10831188 [TBL] [Abstract][Full Text] [Related]
35. The role of hormones in the etiology and prevention of endometrial cancer. Gambrell RD Clin Obstet Gynaecol; 1986 Dec; 13(4):695-723. PubMed ID: 3791826 [TBL] [Abstract][Full Text] [Related]
36. [Menopause and hormone replacement therapy]. Tóth KS Orv Hetil; 2000 Mar; 141(11):547-56. PubMed ID: 10741167 [TBL] [Abstract][Full Text] [Related]
37. Should postmenopausal women be given estrogen? Haber RJ West J Med; 1985 May; 142(5):672-7. PubMed ID: 4013283 [No Abstract] [Full Text] [Related]
38. Use of low-dosage 17 beta-estradiol for the prevention of osteoporosis. Ettinger B Clin Ther; 1993; 15(6):950-62; discussion 949. PubMed ID: 8111815 [TBL] [Abstract][Full Text] [Related]
39. Epidemiology and the menopause: a global overview. Barrett-Connor E Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():6-14. PubMed ID: 8499961 [TBL] [Abstract][Full Text] [Related]
40. Osteoporosis: new hope for the future. Masi L; Bilezikian JP Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]